US Supreme court has rejected lawsuits against Merck & Fosamax over rare atypical femoral Fx and has directed the lower court to reconsider ruling allowing lawsuits against despite the FDA denying Mercks attempt to update the label about fracture risk https://t.co/xvJlDntuuK